Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From ItalySabino Strippoli, Michele Guida, Eustachio Ruggieri et al.|Frontiers in Oncology|2021Cited by 46
Correlation between efficacy and toxicity in pts with pretreated advanced melanoma treated within the Italian cohort of the ipilimumab expanded access programme (EAP).Anna Maria Di Giacomo, Vanna Chiarion‐Sileni, Antonio Maria Grimaldi et al.|Journal of Clinical Oncology|2013Cited by 15
Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell CarcinomaR. Buquicchio, Raffaele Filotico, Valentina Mastrandrea et al.|Frontiers in Oncology|2021Cited by 10
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profilePaolo A. Ascierto, Michele Del Vecchio, Anna Maria Di Giacomo et al.|European Journal of Cancer|2023Cited by 10
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational statusGabriella Guida, Michele Guida, Immacolata Maida et al.|Journal of Translational Medicine|2014Cited by 3